AI assistant
Sending…
STANDARD BIOTOOLS INC. — Director's Dealing 2022
Apr 13, 2022
32853_dirs_2022-04-13_1072f7a7-c7e3-4637-989c-a4560e5670da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2022-04-11
Reporting Person: Caligan Partners LP (10% Owner)
Reporting Person: JOHNSON DAVID EDWARD (10% Owner)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-04-11 | Common Stock, $0.001 par value per share ("Common Stock") | P | 145000 | $3.87 | Acquired | 9034838 | Indirect |
| 2022-04-12 | Common Stock | P | 50000 | $3.60 | Acquired | 9084838 | Indirect |
Footnotes
F1: The securities reported herein are held by an affiliated fund and managed account of Caligan Partners LP ("Caligan"). David Johnson is a Partner of Caligan and a Managing Member of Caligan Partners GP LLC, the general partner of Caligan.
More from STANDARD BIOTOOLS INC.
Proxy Solicitation & Information Statement
2026
Apr 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Director's Dealing
2026
Feb 24
Regulatory Filings
2026
Feb 24
Regulatory Filings
2026
Feb 5
Regulatory Filings
2026
Jan 30